Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Italian Chemical Society and Elsevier recognize three early-career researchers
- 9/13/2019 11:14:11 AM
- The Young Group of the Italian Chemical Society (Società Chimica Italiana, SCI) and Elsevier, a global information analytics business specializing in science and health, are pleased to announce the winners of the 5th Reaxys SCI Early Career Researcher Award during the XXXIX National Congress of the SCI Organic Chemistry Division held this morning in Turin.
- Suing the Pharmaceutical Companies for the Opioid Crisis Isn’t Enough
- 9/12/2019 8:51:16 AM
- Over 400,000 Americans have died in the opioid epidemic. Thousands of lawsuits are winding their way through the courts, accusing pharmaceutical companies of causing the epidemic by misleading doctors and the public about the risks of opioid addiction. Chronic pain expert Cindy Perlin, the creator of the Alternative Pain Treatment Directory and author of “The Truth About …
- Worldepack to attend Sino-Pack2020
- 9/11/2019 9:57:00 AM
- Guangzhou Worlde Packaging Machinery Co., Ltd will attend Sino-Pack2020 in China Import and Export Complex on March 4th to 6th, 2020. Sino-pack is Asia’s top intelligent automatic packaging equipment and material exhibition.
- Pathologie-DNA in the Netherlands selects Elsevier’s diagnostic decision support solution ExpertPath
- 9/11/2019 7:33:48 AM
- Elsevier, a global information analytics business specializing in science and health, has announced an agreement with Pathologie-DNA to implement Elsevier’s ExpertPath solution across its hospital sites in the Netherlands.
- Congress “Returns” to Same Flawed Fixes for Healthcare
- 9/10/2019 8:00:14 PM
- News services are filled with stories about Congress going back into session with an urgent need to fix Americans’ #1 concern: healthcare. Sadly, they won’t get it right, again! Lawmakers apparently are focusing on drug prices and surprise medical billing.
- DePuy Synthes Expands ATTUNE Knee Platform with Cementless Option
- 9/10/2019 2:46:29 PM
- Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** is launching the ATTUNE Cementless Knee in a rotating platform option in select markets around the world.
- Novartis data at ECTRIMS to highlight innovative approach to reimagining care for people living with multiple sclerosis (MS)
- 9/10/2019 2:21:56 PM
- • Novartis will present 34 abstracts from leading MS portfolio, including the highly anticipated results from the Phase III trial of investigational B-cell therapy ofatumumab (OMB157), data for Mayzent ® (siponimod) and Gilenya ® (fingolimod) • Results from head-to-head Phase III ASCLEPIOS studies evaluating efficacy and safety of ofatumumab, an …
- Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants
- 9/10/2019 2:09:11 PM
- Pfizer Inc. (NYSE: PFE) announced positive preliminary results following administration of three doses in a four-dose series for a Proof-of-Concept Phase 2 study (B7471003) to assess safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, being investigated for the prevention of invasive disease and otitis media caused by …
- P&R Dental Strategies Receives Standardized Control Assessment (SCA) Certification, Meeting Strict Information Security Standards
- 9/10/2019 1:52:24 PM
- P&R Dental Strategies, LLC, the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental payer objectives, today announced that after being assessed by ControlCase, LLC, a leading provider of IT Security Certifications and Continuous Compliance Services, its operations have been found to be in compliance with the …
- Independent Pharmacy Alliance (IPA) Announces John Giampolo Jr. Executive Vice President
- 9/9/2019 9:50:34 PM
- The Independent Pharmacy Alliance (IPA), one of the largest pharmacy Group Purchasing Organizations (GPO) and Trade Organizations in the United States serving over 3,150 independent retail pharmacies, is very happy to announce the addition of John Giampolo Jr.
- Medical Practices: Then and Now
- 9/9/2019 9:48:48 PM
- Technological advancements dominate the various fields of science, most especially the field of medicine. Ever since technology dawned on humanity, the field of medicine changed drastically.
- Africa Public Health Foundation to Address Epidemic Preparedness and Response
- 9/5/2019 11:44:38 AM
- · An acute public health event in Africa is reported every four days and the costs of infectious disease crises are rising · The new Africa Public Health Foundation will support the Africa Centres for Disease Control and Prevention The Africa Centres for Disease Control and Prevention ( Africa CDC ), in partnership with the African Union and World Economic Forum, today …
- ZEISS Showcases New CIRRUS 6000 OCT System at the European Society of Retina Specialists 2019 Congress
- 9/5/2019 3:09:57 AM
- ZEISS Medical Technology Segment expands its *CIRRUS® — the most trusted Optical Coherence Tomography (OCT) with the launch of its new CIRRUS 6000, 100kHz ultra-fast OCT system that promises to dramatically elevate the efficiency of advanced care practices.
- Merck Grant to Support Smithsonian Future Exhibition on History of American Medicine
- 9/4/2019 12:14:06 PM
- Merck recently awarded a $500,000 grant to the Smithsonian’s National Museum of American History to use for developing an exhibition and programming on the history of American medicine in recognition of the work of Dr.
- #ConV2X 2019 Network Media Event Announces Event Speakers
- 9/3/2019 8:00:00 AM
- In its 3rd year, the blockchain and telehealth technology conference #ConV2X 2019 presents “Proving Market Value with Pragmatic Innovation in Healthcare,” in tandem with its new media distributor, Trader News Network, the first Independent Syndicated Financial News Show in the USA, scheduled for October 15, in Boston, MA.
- UN health experts warn ‘dramatic resurgence’ of measles continues to threaten the European region
- 8/29/2019 11:48:44 AM
- Europe has lost ground in eliminating measles, as the number of countries having achieved or sustained elimination of the disease has declined, the European Regional Verification Commission for Measles and Rubella Elimination (RVC) warned on Thursday. “If high immunization coverage is not achieved and sustained in every community, both children and adults will suffer …
- WHO revises recommendations on hormonal contraceptive use for women at high HIV risk
- 8/29/2019 11:39:32 AM
- The World Health Organization (WHO) has revised its guidance on contraceptive use to reflect new evidence that women at high risk of HIV can use any form of reversible contraception, including progestogen-only injectables, implants and intrauterine devices (IUDs), without an increased risk of HIV infection.
- New Clinical Recliner to Serve Essential Needs of Caregivers
- 8/28/2019 4:18:13 PM
- The Alō Infusion Recliner is the newest seating selection by premier medical seating company, Champion Manufacturing Inc. Widely known for their portfolio of recliners with true clinical effectiveness, the Alō has raised the bar with unique customization options that transform the recliner to a beautiful piece of furniture.
- Johnson & Johnson To Appeal Flawed Opioid Judgment in Oklahoma
- 8/27/2019 11:48:08 AM
- Johnson & Johnson (NYSE: JNJ) and its Janssen Pharmaceutical Companies announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of Oklahoma’s lawsuit against opioid manufacturers.
- ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months
- 8/26/2019 11:37:17 AM
- ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV. The study …
